Aurion Biotech, Inc. plans $100M IPO for corneal disease treatments, limited competition, Phase 1/2 trials underway with ...

In recent company developments, MAIA Biotechnology, Inc., a pharmaceutical preparations company valued at $54.93 million, has ...

Being a good mom isn’t about never questioning yourself—it’s about loving your child enough to want to do right by them. You ...

Contract research firm IQVIA Holdings beat Wall Street estimates for fourth-quarter profit and revenue on Thursday, helped by the demand for its healthcare data and analytics services.

The FDA recently approved a bioengineered blood vessel, which becomes part of a patient’s body over time. It’s designed to ...

Revolution Medicines, Inc. (NASDAQ:RVMD), a biotechnology company focused on developing novel therapies for cancer, has been making significant strides in its clinical pipeline, particularly in the ...

What may be the first commercially available book saved in DNA is the latest example of how consumers might use molecular data storage.

Invest for the long haul with a balanced portfolio. Find out why these three stocks are ideal for stability, income, and ...

The post-consolidated Common Shares are delivered by the Company’s transfer agent to shareholders holding book shares ... a clinical-stage biotechnology company that develops novel immunotherapies to ...

Quince Therapeutics, Inc. (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient's own biology for the treatment of rare diseases. For more information on ...

If the 118th Congress does not reauthorize the farm bill, it will be incumbent upon the 119 th Congress to pass an updated farm bill as quickly as possible. The farm bill is a critical tool for ...

Jilin, China, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited ... LLC ("Kingswood") acted as the sole book-running manager for the Offering. Hunter Taubman Fischer ...